Adenocarcinoma of the esophagus and cardia: a review of the disease and its treatment.
DeMeester SR.
Ann Surg Oncol. 2006 Jan;13(1):12-30. doi: 10.1245/ASO.2005.12.025. Epub 2006 Jan 1.
Trends in incidence and prevalence of specialized intestinal metaplasia, barrett's esophagus, and adenocarcinoma of the gastroesophageal junction.
Pera M.
World J Surg. 2003 Sep;27(9):999-1008; discussion 1006-8. doi: 10.1007/s00268-003-7052-2. Epub 2003 Aug 18.
The Early Diagnostic Value of Serum Interleukin-8 in Esophagogastric Junction Adenocarcinoma.
Li Z, Xu H, Yu J, Liu C, Zheng C, Zeng R, Xu L, Li E, Peng Y, Xu Y.
Cancer Control. 2021 Jan-Dec;28:10732748211004883. doi: 10.1177/10732748211004883.
Diagnosis of esophagogastric tumors.
Lambert R.
Endoscopy. 2004 Feb;36(2):110-9. doi: 10.1055/s-2004-814178.
Bone marrow-disseminated tumor cells in patients with carcinoma of the esophagus or cardia.
Bonavina L, Soligo D, Quirici N, Bossolasco P, Cesana B, Lembertenghi Deliliers G, Peracchia A.
Surgery. 2001 Jan;129(1):15-22. doi: 10.1067/msy.2001.109503.
Oxaliplatin and capecitabine in patients with metastatic adenocarcinoma of the esophagus, gastroesophageal junction and gastric cardia: a phase II study from the North Central Cancer Treatment Group.
Jatoi A, Murphy BR, Foster NR, Nikcevich DA, Alberts SR, Knost JA, Fitch TR, Rowland KM Jr; North Central Cancer Treatment Group.
Ann Oncol. 2006 Jan;17(1):29-34. doi: 10.1093/annonc/mdj063. Epub 2005 Nov 22.
Establishment of cell lines from adenocarcinomas of the esophagus and gastric cardia growing in vivo and in vitro.
de Both NJ, Wijnhoven BP, Sleddens HF, Tilanus HW, Dinjens WN.
Virchows Arch. 2001 May;438(5):451-6. doi: 10.1007/s004280000358.
Carcinoma of the cardia: classification as esophageal or gastric cancer?
von Rahden BH, Feith M, Stein HJ.
Int J Colorectal Dis. 2005 Mar;20(2):89-93. doi: 10.1007/s00384-004-0646-9. Epub 2004 Oct 26.
Prevalence, management and outcome of early adenocarcinoma (pT1) of the esophago-gastric junction. Comparison between early cancer in Barrett's esophagus (type I) and early cancer of the cardia (type II).
Ruol A, Merigliano S, Baldan N, Santi S, Petrin GF, Bonavina L, Ancona E, Peracchia A.
Dis Esophagus. 1997 Jul;10(3):190-5. doi: 10.1093/dote/10.3.190.
Downregulation of Potential Tumor Suppressor miR-203a by Promoter Methylation Contributes to the Invasiveness of Gastric Cardia Adenocarcinoma.
Liu W, Dong Z, Liang J, Guo X, Guo Y, Shen S, Kuang G, Guo W.
Cancer Invest. 2016 Nov 25;34(10):506-516. doi: 10.1080/07357907.2016.1242010. Epub 2016 Oct 28.
